PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50120C00171 — EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. is a federal NONE award for Department of Health and Human Services (HHS) held by INVIRSA INC. Estimated value $39M ($22M obligated). Current period of performance ends Nov 16, 2028. Last award drew 1 bidder.

$39M
Estimated Value
$22M
Obligated
Nov 16, 2028
PoP End / Expires
1
Bidders (last award)
INVIRSA INC
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

INVIRSA INC holds $22.0M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Nov 16, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50120C00171
AgencyDepartment of Health and Human Services (HHS)
IncumbentINVIRSA INC
UEISN3VBD5EQMK6
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAZ13
PoP end (current)Nov 16, 2028
Obligated$22M

EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

Recompete timing

Public
Expiring in 823 days

Current PoP ends Nov 16, 2028 (823 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around May 16, 2027.

Watch this contract — one email →

Incumbent footprint

Public record

INVIRSA INC$22.0M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$22.0M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open INVIRSA INC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50120C00171?

75A50120C00171 (EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.) is a Department of Health and Human Services (HHS) award with an estimated value of $39M, currently held by INVIRSA INC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50120C00171?

INVIRSA INC is the incumbent with $22.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Nov 16, 2028.

When does 75A50120C00171 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 16, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50120C00171